264 related articles for article (PubMed ID: 6376979)
1. [Use of etretinate (RO-10-9359) in intermittent doses and follow-up for 1 year in patients with psoriasis. Final report].
Domínguez Soto L; Hokyo Tomoka MT; Armas JJ
Med Cutan Ibero Lat Am; 1984; 12(1):47-56. PubMed ID: 6376979
[TBL] [Abstract][Full Text] [Related]
2. A three-year follow-up study of psoriasis patients treated with low dosages of etretinate orally and corticosteroids topically.
Polano MK; van der Rhee HJ; van der Schroeff JG
Acta Derm Venereol; 1982; 62(4):361-4. PubMed ID: 6183880
[TBL] [Abstract][Full Text] [Related]
3. [Psoriasis therapy with the aromatic retinoid Ro 10-9359 (Tigason)].
Sönnichsen N; Harnack K; Barth J; Heilmann S; Jäger K; Metz D; Schiller F
Z Hautkr; 1983 Sep; 58(17):1257-67. PubMed ID: 6636927
[TBL] [Abstract][Full Text] [Related]
4. Tigason (etretinate) treatment in psoriatic arthritis.
Ciompi ML; Bazzichi L; Marotta G; Pasero G
Int J Tissue React; 1988; 10(1):25-7. PubMed ID: 3397251
[TBL] [Abstract][Full Text] [Related]
5. Treatment of psoriatic arthropathy with etretinate: a two-year follow-up.
Chieregato GC; Leoni A
Acta Derm Venereol; 1986; 66(4):321-4. PubMed ID: 2430403
[TBL] [Abstract][Full Text] [Related]
6. [Side effects of oral retinoid Ro 10-9359 on the unaffected skin of psoriatic patients: retinoid dermatitis].
Rüst O; Tufli T
Schweiz Med Wochenschr; 1979 Dec; 109(48):1921-5. PubMed ID: 161414
[TBL] [Abstract][Full Text] [Related]
7. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
Mahrle G; Meyer-Hamme S; Ippen H
Arch Dermatol; 1982 Feb; 118(2):97-100. PubMed ID: 7059226
[TBL] [Abstract][Full Text] [Related]
8. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation.
Frati C; Bevilacqua L; Apostolico V
Acta Derm Venereol Suppl (Stockh); 1994; 186():151-3. PubMed ID: 8073820
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of plaque psoriasis with an aromatic retinoid (etretinate)].
Melis M
Rev Med Chil; 1984 Jan; 112(1):20-5. PubMed ID: 6377426
[No Abstract] [Full Text] [Related]
10. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T
Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606
[TBL] [Abstract][Full Text] [Related]
11. Etretinate therapy in generalized pustular psoriasis (Zumbusch type). Immediate and long-term results.
Wolska H; Jabłonska S; Langner A; Fraczykowska M
Dermatologica; 1985; 171(5):297-304. PubMed ID: 3908171
[TBL] [Abstract][Full Text] [Related]
12. Oral retinoid for psoriasis. A report of a double blind study.
Pettit JH
Acta Derm Venereol Suppl (Stockh); 1979; 59(85):133-6. PubMed ID: 393035
[TBL] [Abstract][Full Text] [Related]
13. [Clinical experience with etretinate (Tigason) in 26 patients with psoriasis].
Gajardo J
Rev Med Chil; 1989 May; 117(5):516-22. PubMed ID: 2519162
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream compared with etretinate alone in moderate-severe psoriasis.
Giannetti A; Coppini M; Bertazzoni MG; Califano A; Altieri E; Pazzaglia A; Lega M; Lombardo M; Pelfini C; Veller Fornasa C; Rabbiosi G; Cespa M
J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):91-5. PubMed ID: 10568486
[TBL] [Abstract][Full Text] [Related]
15. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.
Magis NL; Blummel JJ; Kerkhof PC; Gerritsen RM
Eur J Dermatol; 2000; 10(7):517-21. PubMed ID: 11056421
[TBL] [Abstract][Full Text] [Related]
16. [Combined oral retinoid and PUVA therapy in the treatment of psoriasis and psoriatic arthropathy (author's transl)].
Thivolet J; Robart S; Vignon E
Ann Dermatol Venereol; 1981; 108(2):131-7. PubMed ID: 6972721
[TBL] [Abstract][Full Text] [Related]
17. [Unusual side effects in patients with psoriatic erythroderma treated with etretinate (RO 10-9359)].
Castel T; Castro J; Lecha M; Mascaró JM
Med Cutan Ibero Lat Am; 1986; 14(2):83-6. PubMed ID: 2943953
[TBL] [Abstract][Full Text] [Related]
18. [Clinical experience with Tigason 10 mg].
Forte M
G Ital Dermatol Venereol; 1982; 117(4):XXXI-XXXIV. PubMed ID: 6227553
[No Abstract] [Full Text] [Related]
19. Etretinate therapy causes increases in lipid levels in patients with psoriasis.
Ellis CN; Swanson NA; Grekin RC; Goldstein NG; Bassett DR; Anderson TF; Voorhees JJ
Arch Dermatol; 1982 Aug; 118(8):559-62. PubMed ID: 7103524
[TBL] [Abstract][Full Text] [Related]
20. [Etretinate in familial pustular psoriasis].
Schewach-Millet M; Shifer O; Ziv R
Harefuah; 1986 Sep; 111(5-6):112-3. PubMed ID: 3804054
[No Abstract] [Full Text] [Related]
[Next] [New Search]
